Last reviewed · How we verify
Serology
At a glance
| Generic name | Serology |
|---|---|
| Also known as | Diagnostics |
| Sponsor | Tejs Ehlers Klug |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users (N/A)
- Eliminación de la infección Por el Virus de la Hepatitis C en PWID en Los Estados Del Norte de México (N/A)
- Studies on Current and Past SARS-CoV-2 Infection (and COVID-19) in Healthcare in Stockholm, Sweden (N/A)
- Infections in Migrants in Sweden - the Importance of Malaria and Other Parasitic Infections (N/A)
- Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy (NA)
- Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group (NA)
- The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain (Phase 4)
- A Cross-Sectional Study to Estimate the Influence of Malnutrition, Diabetes Mellitus and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian Population (N/A)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Serology CI brief — competitive landscape report
- Serology updates RSS · CI watch RSS
- Tejs Ehlers Klug portfolio CI